Difenidrin

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Difenidrin

Quick Facts

Feature Detail
Drug Class First-Generation Antihistamine
Primary Mechanism Histamine H1-receptor antagonist
Common Uses Allergies, insomnia, motion sickness
Availability Over-the-counter (OTC) in many countries

Difenidrin is an apparent alternate spelling or regional name for Diphenhydramine, a medication classified as a first-generation antihistamine. This drug is widely accessible as an over-the-counter (OTC) product and is employed to treat a variety of conditions related to histamine release and its central nervous system effects.

Mechanism and Therapeutic Uses

Diphenhydramine functions primarily as a histamine H1-receptor antagonist. It works by blocking the activity of histamine, a chemical mediator involved in allergic reactions, which helps relieve common symptoms such as sneezing, itching, runny nose, and watery eyes.

Beyond its use for allergies, the drug is also utilized for other purposes due to its secondary properties:

  • Sleep Aid: Its ability to easily cross the blood-brain barrier induces drowsiness, making it a common component in many non-prescription medications marketed for the short-term management of insomnia.
  • Motion Sickness: The drug’s anticholinergic effects contribute to its effectiveness in preventing and treating symptoms of motion sickness, including nausea and dizziness.

It is important to note that while Diphenhydramine provides symptomatic relief, professional guidelines recommend against its use for chronic insomnia due to concerns about long-term effectiveness and the risk of side effects.

Regulatory References

  1. MedlinePlus Drug Information

What side effects are possible with Difenidrin?

Possible Side Effects and Safety Information

This section details the officially documented adverse effects and safety statements for Difenidrin (Diphenhydramine) based strictly on governmental regulatory prescribing information (e.g., FDA, EMA).

Adverse Reactions and Frequencies

Side effects are formally classified by frequency in regulatory documents, with effects organized by the body system affected (System-Organ Class or SOC). Somnolence (drowsiness) is typically classified as Very Common (ge 1/10).

Frequency Examples of Officially Listed Effects
Common Dry mouth, sedation, dizziness, disturbance in attention, fatigue.
Uncommon Confusion, agitation, headache, nausea, blurred vision, palpitations.
Rare / Not Known Anaphylaxis, hemolytic anemia, thrombocytopenia, convulsions.

Serious Reactions and Safety Constraints

Serious Adverse Reactions officially documented, though rare, include severe hypersensitivity like anaphylactic shock and certain effects on blood cells, such as agranulocytosis. These are listed under Blood and Lymphatic System Disorders.

Population-Specific Safety Notes

Regulatory labeling highlights differences in risk for certain groups:

  • Older Adults: More likely to experience confusion, dizziness, and sedation, potentially increasing the risk of falls.
  • Children: May experience paradoxical excitation (restlessness and agitation) instead of or before exhibiting sedative effects.
  • Existing Conditions: Use is constrained in patients with conditions like narrow-angle glaucoma or urinary retention due to prostatic hypertrophy.

Due to the risk of impaired judgment and motor skills, the official labeling includes a safety restriction: individuals taking this medicine should not drive or operate machinery. The use of alcohol or other Central Nervous System depressants should be avoided due to the potential for enhanced sedation.

Overdose and Emergency Response

Overdose and when to seek help

Overdose Scope Official Regulatory Information
Documented Presentations Overdosage may present with Central Nervous System (CNS) effects ranging from profound somnolence to paradoxical stimulation, including excitement, agitation, and hallucinations. Documented anticholinergic signs include mydriasis (fixed, dilated pupils), dry mouth, and urinary retention. The physiological systems affected are the CNS, Cardiovascular, and Respiratory systems.
Severity and Risks The overdose can be severe, life-threatening, or fatal, with documented risks including respiratory depression and cardiovascular collapse. Overdose may lead to serious cardiac effects, including QT interval prolongation and severe cardiac arrhythmias. CNS stimulation is particularly likely in pediatric patients, while the elderly may be more sensitive to CNS depression.
Mandated Emergency Action Medical attention must be sought immediately if a person is hallucinating, cannot be awakened, has a seizure, or has trouble breathing. Individuals should contact a Poison Control Center or emergency number immediately.
Management Notes (Regulatory Context)
Supportive Measures Treatment is documented as symptomatic and supportive, as no specific antidote is known. Required emergency management may include the potential administration of activated charcoal. Continuous ECG monitoring is an officially described procedure due to the risk of significant cardiac events.

Therapeutic Uses of Difenidrin

What Difenidrin Treats: Main Uses and Benefits

Difenidrin (Diphenhydramine) is commonly used across domains where symptoms associated with acute or episodic changes may create noticeable physiological strain, contributing to easing the overall symptom load. It is applied in therapeutic areas including allergic reactions, transient insomnia, and motion sickness.

Managing Acute Allergic Discomfort

This medication is generally used across conditions presenting with acute episodes where symptoms relate to heightened physiological activity. It is used for managing symptom clusters that may become noticeable or disruptive, such as pruritus (itching), urticaria (hives), sneezing, and a runny nose. Applied during phases when symptoms become more noticeable, it contributes to improved comfort during periods of heightened symptoms and may assist with maintaining functional stability.

Quick Fact Block

Therapeutic Focus Primary Benefit
Acute Allergic Episodes Supports comfort and helps ease itching/sneezing.
Transient Insomnia May assist with sleep onset during short-term disruption.
Motion Sickness Helps manage and prevent nausea and dizziness during travel.

Controlling Travel Sickness and Movement Symptoms

Difenidrin is commonly used when short-term symptomatic assistance is needed in situations involving symptoms related to systemic imbalance, such as motion sickness. It helps address pronounced manifestations of nausea, dizziness, and vomiting often experienced during travel. It is also relevant for managing certain drug-induced involuntary movement problems, supporting the patient during difficult episodes by managing symptoms of increased physical discomfort.

Regulatory References

  1. NIH MedlinePlus overview

Eligibility and Restrictions for Use

Who can and cannot use Difenidrin?

This section describes the population eligibility rules for Difenidrin (Diphenhydramine) as defined by government regulatory documents, including groups who are strictly prohibited from use and those requiring caution.

Contraindicated and Prohibited Groups

Use of Difenidrin is contraindicated in neonates and premature infants, as well as in nursing mothers (breastfeeding women) due to the risk of serious adverse effects on the infant. The medicine is also contraindicated for patients with a known hypersensitivity to the drug or chemically similar antihistamines.

Age and Comorbidity Restrictions

Population Group Eligibility Status (Regulatory Wording)
Children under 6 years OTC use is generally not recommended; use in children under 2 years is often prohibited.
Older Adults (Geriatric) Use requires caution due to increased risk of dizziness and sedation; avoid use in the confused elderly.
Pregnancy Use is not recommended during the third trimester; Category B for other stages, for use only if clearly needed.
Specific Comorbidities Use with considerable caution if the patient has narrow-angle glaucoma, symptomatic prostatic hypertrophy, stenosing peptic ulcer, or severe hepatic/renal impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Difenidrin (Diphenhydramine) documents several clinically significant drug-drug and drug-substance interaction patterns, classified primarily by their effect on central nervous system function and metabolic clearance.

Pharmacodynamic Interactions and Restrictions

Co-administration with alcohol and other Central Nervous System (CNS) depressants (such as opioid analgesics, hypnotics, and sedatives) produces an additive effect, resulting in potentiated sedation. Use of alcohol must be avoided. The drug’s inherent antimuscarinic activity is intensified and prolonged when co-administered with Monoamine Oxidase Inhibitors (MAOIs) or other anticholinergic drugs, including tricyclic antidepressants. Official labeling formally prohibits the concurrent use of Difenidrin with any other antihistamine-containing preparations.


Pharmacokinetic and Exposure Effects

Difenidrin is documented as an inhibitor of the cytochrome P450 isoenzyme CYP2D6. This pharmacokinetic interaction is clinically significant because it reduces the clearance of medicines primarily metabolized by this enzyme, such as metoprolol and venlafaxine, thereby increasing their systemic exposure. Caution is advised when administering Difenidrin within two weeks of stopping an MAOI. In elderly patients, the risk of interaction-related effects, including dizziness and sedation, is officially noted as heightened.

Mechanism of Action

Difenidrin (Diphenhydramine) functions as a first-generation H1 histamine receptor inverse agonist in both peripheral tissues and the central nervous system (CNS). By inversely agonizing the H1 receptor, Difenidrin stabilizes it in its inactive state, thereby suppressing the constitutive activity of the receptor and preventing the actions of endogenous histamine. This molecular interaction primarily modulates signaling cascades involving phospholipase C and intracellular calcium mobilization, counteracting the effects of mast cell and basophil degranulation throughout the body.

Additionally, Difenidrin exhibits competitive antagonist activity at central and peripheral muscarinic acetylcholine receptors (primarily M1 and M2 subtypes). This anticholinergic interaction disrupts cholinergic neurotransmission. Furthermore, Difenidrin crosses the blood-brain barrier to target CNS H1 receptors, leading to significant modulation of wakefulness and alertness centers. Its activity also includes blockade of intracellular sodium channels, which imparts localized inhibitory effects on nerve impulse propagation. The combination of these molecular actions results in systemic physiological consequences, including reduced smooth muscle contraction in the airways and gastrointestinal tract, decreased vascular permeability, and central nervous system sedation.

Dosage and Administration Information

Difenidrin is administered via three primary official routes: oral (tablets, capsules, liquid), parenteral (intramuscular or intravenous injection), and topical (creams or gels). The injection route is typically reserved for acute conditions where oral administration is considered impractical. The standardized adult dose for general use is 25 mg to 50 mg taken every 4 to 6 hours.

Use Context Adult Dose & Frequency Maximum Limit
Oral (General) 25 mg to 50 mg every 4 to 6 hours. 300 mg per 24 hours (Oral)
Oral (Insomnia) A single 50 mg dose taken at bedtime. 400 mg per 24 hours (Parenteral)

Oral forms may be taken with or without food. For symptoms related to motion, the first oral dose is usually administered approximately 30 minutes before the start of travel. Parenteral dosing ranges from 10 mg to 50 mg and has a maximum daily limit of 400 mg. When administered intravenously, the official rate of injection must be controlled, generally not exceeding 25 mg per minute. Special administration rules include using an accurate measuring device for liquid formulations. Additionally, official documents recommend starting with lower initial doses for older adult patients. Use for temporary insomnia should be limited to short-term use, officially not continuous for longer than two weeks.

Recent Clinical Evidence

Research evidence / Overview of studies for Difenidrin

Difenidrin (Diphenhydramine) has been the subject of numerous clinical investigations, primarily focused on its short-term use across several common conditions. The research landscape for this medication is characterized by a mix of older and newer studies, including Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews.


Evidence for Use in Acute Allergic Discomfort

Research exploring short-term symptom changes was conducted using RCTs and other controlled study designs. These studies focused on measuring outcomes related to physical discomfort during phases of heightened symptom activity, such as sneezing, runny nose, and various forms of itching (pruritus). Studies monitored short-term changes, and findings describe patterns observed in the immediate hours following administration for short-term changes in symptoms. Additionally, research examined central nervous system (CNS) effects, such as changes in psychomotor performance and the presence of sedation, which was relevant in trials assessing short-term or episodic symptom patterns.

The existing studies focus on acute use, meaning that long-term outcomes are not well characterized regarding sustained symptom management. Comparative evidence against newer treatments often requires accounting for the observation of CNS effects.


Evidence for Use in Transient Sleep Difficulty

Research has explored Difenidrin for conditions associated with transient sleep difficulty in RCTs, typically in placebo-controlled settings. The outcomes monitored included objective measures of the time taken to fall asleep (sleep onset latency), and patient-reported outcomes describing perceived discomfort or sleep quality. Research highlights patterns of change measured during the study period, including observations of a shorter time to fall asleep in acute settings. However, studies also described patterns showing that the observation of these changes may diminish with repeated, continuous use over several nights.

The evidence is limited regarding outcomes for long-term or chronic insomnia, as the follow-up durations were typically short-term. Data for certain groups remain insufficient, particularly for older adults, where findings described patterns of residual effects that were noted.


Evidence for Use in Motion and Movement Symptoms

Evidence for Difenidrin was studied for conditions involving periods of heightened symptoms related to motion and systemic imbalance. Evidence has been derived from Clinical Literature Reviews and controlled studies, often evaluating its use prophylactically (preventively). The outcomes monitored included the prevention of nausea, vomiting, and dizziness. Data show patterns related to short-term changes and are often rooted in the drug's established mechanism of action.

Comparative evidence is lacking in large-scale RCTs that focus on treating existing, severe motion sickness symptoms rather than prevention. Furthermore, data for certain groups remain insufficient.

Key Studies & References

  1. Diphenhydramine: MedlinePlus Drug Information
  2. Diphenhydramine: NIH StatPearls [Internet]

Frequently Asked Questions (FAQ)

Common questions about Difenidrin (FAQ)


Q: How long does a dose of Difenidrin usually stay in your system?

Official product information indicates that the drug is metabolized, or broken down, primarily in the liver. Most of the metabolic degradation products are almost completely removed from the body and excreted within 24 hours of administration. Only a very small amount of the original, unchanged drug is typically eliminated via the urine.


Q: What are the signs of a severe allergic reaction to Difenidrin?

While rare, official labeling mentions the risk of severe hypersensitivity reactions, including anaphylaxis. Signs of a severe reaction that require immediate medical attention can include difficulty breathing, hives, or swelling of the face, tongue, or throat. Furthermore, in cases of suspected overdose, life-threatening symptoms such as seizures, coma, or irregular heart rhythm may occur.


Q: Can I take pain relievers like Tylenol (acetaminophen) while using Difenidrin?

Regulatory documents specifically advise against combining Difenidrin with other Central Nervous System (CNS) depressants or anticholinergic drugs. Common non-sedating pain relievers like acetaminophen (Tylenol) or ibuprofen are not typically listed as being strictly prohibited. Individuals are encouraged to discuss all over-the-counter medications and supplements with a healthcare professional to check for potential specific interactions.


Q: Is it safe to drive or operate machinery after taking Difenidrin?

Official regulatory labeling indicates that individuals should avoid driving or operating heavy machinery. This restriction is due to the potential for common side effects like drowsiness, dizziness, and impaired judgment or motor skills, which can significantly increase safety risks.


Q: Is there a specific time of day that is best to take Difenidrin?

Official usage guidance provides specific timing recommendations for certain indications. For example, when used for temporary sleep difficulty (insomnia), the recommended dosing is a single dose taken at bedtime. For motion sickness prevention, the first dose is usually administered about 30 minutes before the start of travel.


Q: What is the difference between the brand-name and generic versions of Difenidrin?

Generic versions contain the same active ingredient, Diphenhydramine, as the brand-name product. Generic drugs must meet the same strict quality and effectiveness standards required by regulatory bodies. The primary differences may involve inactive ingredients, such as the different colors or fillers used in the product formulation.


Q: Can Difenidrin be crushed, split, or chewed?

Official regulatory documents specify that Difenidrin is available in various forms, including tablets, capsules, and liquids. Official guidance often recommends swallowing tablets or capsules whole unless the manufacturer's directions or a healthcare provider specifically advise altering the form.


Q: Does Difenidrin interact with herbal supplements like St. John's Wort?

Official drug labels prohibit the concurrent use of Difenidrin with Monoamine Oxidase Inhibitors (MAOIs). While specific herbal supplements are not always explicitly listed in regulatory documents, individuals who are taking herbal products or supplements are advised to discuss these with a healthcare professional to identify and manage potential drug interactions.


Q: Are there generic versions of Difenidrin available?

Yes, the active ingredient in Difenidrin, Diphenhydramine, is widely available as a generic drug. This generic formulation is often sold over-the-counter (OTC) in many countries for approved uses like allergy symptom relief and temporary sleep aid.


Q: What happens if I miss a dose of Difenidrin?

General regulatory advice for managing a missed dose often suggests taking it as soon as it is remembered, if the individual is following a regular schedule. If it is already close to the time for the next scheduled dose, the missed dose should be skipped. Regulatory warnings typically advise against taking a double dose to make up for a missed dose.


Q: What should I do if I accidentally take two doses of Difenidrin close together?

The official warning indicates that individuals should not exceed the recommended dose listed on the product label. In the event of a suspected overdose, regulatory information recommends seeking emergency medical attention or contacting a Poison Control Center immediately.


Q: Is Difenidrin known to be habit-forming or addictive?

Regulatory bodies have issued warnings regarding the abuse and misuse of high doses of Diphenhydramine, which can lead to serious health problems. Additionally, professional monographs report that the body may develop a tolerance to the drug’s effects, particularly the sedating property, with repeated use.


Q: Is Difenidrin available without a prescription in some places?

Yes, for several of its approved uses, such as allergy symptom relief and temporary sleep difficulty, the active ingredient Diphenhydramine is widely sold as an over-the-counter (OTC) medication in many countries.


Q: Are there any specific lab tests needed while taking Difenidrin?

Official labeling indicates that Difenidrin can interfere with the results of certain medical tests, specifically allergy skin tests. Individuals are advised to inform their healthcare providers that they are taking this medicine before any allergy testing is performed.


Q: Does Difenidrin interact with birth control pills?

Official regulatory documents do not typically list specific oral contraceptives as a major drug-drug interaction with Difenidrin. Individuals taking hormonal contraceptives are encouraged to inform their healthcare providers about all medications they are taking to verify any potential interactions.


Q: Is it possible to develop a tolerance to the effects of Difenidrin?

Yes, regulatory data indicates that tolerance can develop to the effects of Difenidrin, especially with continuous use. For example, studies show that the drug’s effectiveness in reducing the time it takes to fall asleep may lessen when it is used repeatedly over several consecutive nights.


Q: Are there specific symptoms that mean I should stop taking Difenidrin immediately?

Immediate medical attention is recommended if serious side effects are experienced. Regulatory warnings indicate that use of the medication should be discontinued, and medical help should be sought for symptoms such as pounding or irregular heartbeats, difficulty or pain when urinating, significant confusion, or the onset of seizures.


Q: How is Difenidrin eliminated from the body?

The medicine is processed extensively in the liver through metabolic breakdown. The breakdown products are then eliminated from the body, primarily through the kidneys via urine. Most of the drug's byproducts are typically removed within a day.


Q: Are there any warning signs that the Difenidrin isn't working for me?

Official regulatory guidance notes that if the symptoms being treated do not improve or begin to worsen after approximately 7 days of treatment, consulting a healthcare provider is recommended. Lack of improvement after this period may be a warning sign of ineffectiveness.

How should Difenidrin be stored and disposed of?

How to Store and Dispose of Difenidrin? — Official Regulatory Information

The substance Difenidrin is not currently recognized or listed in the official regulatory documentation of major government drug agencies (such as the EMA, FDA, Health Canada, or TGA) under this name. Consequently, no specific, mandatory storage, stability, handling, or disposal requirements have been officially documented by these authoritative sources.

Storage & disposal scope Requirement as per Official Labeling
Labeled storage temperature Not defined in official regulatory documents.
Light/moisture protection Not defined in official regulatory documents.
Child-protection storage Not defined in official regulatory documents.
Disposal instructions Not defined in official regulatory documents.

In the absence of drug-specific instructions, the most recommended disposal method for unused or expired medicines globally is to use a community drug take-back program or mail-back envelope. If a take-back option is unavailable, the general household trash disposal method involves mixing the medicine with an unpalatable substance (like dirt or used coffee grounds) and placing it in a sealed container before discarding it. Always check the container for any listed instructions and keep all medicines away from children.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Difenidrin found in:

A-Z Index: